Investing

Cathie Wood's ARK Invest Sells Over 400,000 More Shares of Pfizer

Chris Lange

Published: November 12, 2021 7:50 am

Here is yet another day when an ARK Invest exchange-traded fund run by ETF star Cathie Wood parted with even more Pfizer Inc. (NYSE: PFE) shares. Specifically, the fund sold over 400,000 more shares, as the price of this ETF was flat in the day’s session. However, it is up in the past year.
[in-text-ad]
It was ARK Genomic Revolution ETF (NYSEARCA: ARKG) that shed 407,075 shares of Pfizer. At Thursday’s closing price, this would have valued this sale at roughly $20.4 million. This is only a small fraction of the total holdings. The fund is up about 1.5% over the past 52 weeks.

Check out all the ARK Invest sales for Thursday:

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.

24/7 Wall St.
5 Safe Dividend Aristocrats to Buy After This Week’s Very Alarming Inflation Data

Get Ready To Retire ^(Sponsored)

Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future